Njiiri Karago/MSF
Analysis
09/16/2022
Rony Brauman
In this article, Rony Brauman identifies the dynamics and events that made bending the HIV/AIDS epidemic curve possible. He explains the climate in which the tug-of-war with parts of the pharmaceutical industry played out from MSF’s perspective, and recalls that fears about international security and political stability also helped push governments to mobilise against the epidemic.
Read more
Analysis
11/14/2021
Elba Rahmouni
Pierre Mendiharat
Léon Salumu Luzinga
This article was first released in the 18th volume of the Humanitarian Alternatives magazine. Designed to reduce the incidence of HIV/AIDS in a Kenyan district, a Médecins Sans Frontières project successfully exceeded the “90-90-90” target set by UNAIDS. A look back on the results that the authors of this article - Pierre Mendiharat, Deputy director of operations at MSF France and Léon Salumu Luzinga, Program manager at MSF France, interviewed by Elba Rahmouni - believe are encouraging but by no means a guarantee that the epidemic will be over by 2030.
Read more
Abayomi Akande
Interview
05/05/2022
Jean-Hervé Bradol
Elba Rahmouni
All the warning lights are flashing red this year: drought, the high prices of grains and fertilisers exacerbated by the war in Ukraine, reduced imports and speculation, numerous armed conflicts, a record number of refugees to be fed, disengagement of institutional donors,… With the exception of locusts, all the determinants of severe food scarcity are there, from Afghanistan to the Sahel, including Yemen, the Horn of Africa, and the Indian subcontinent. To the point of threatening all of the progress that was made in treating undernutrition after the 2005 crisis in Niger, which was the starting point for global advances in managing malnutrition in places where it is commonplace. It is time for a general mobilisation to limit the scale of the coming catastrophe. Interview with Jean-Hervé Bradol by Elba Rahmouni.
Read more
MSF
Book
04/01/2022
Vanja Kovacic
Reconstructing Lives: Victims of war in the Middle East and Médecins Sans Frontières was published in January 2022 by Manchester University Press. The book is the result of extensive fieldwork, in collaboration with the Crash. It is fully available on our website.
Read more
Conference
12/09/2021 - 06:30 PM 08:30 PM
Yves Clot
Jean-Yves Bonnefond
The members of the Crash were very happy to welcome you all to this new conference-debate with occupational psychologists Yves Clot and Jean-Yves Bonnefond, two of the authors of “Le prix du travail bien fait – La coopération conflictuelle dans les organisations” (Paris, La Découverte, 2021 ; co-written with Antoine Bonnemain and Mylène Zittoun).
Read more
Book
10/01/2007
Xavier Crombé
Jean-Hervé Jézéquel
Twenty years after the charity concerts for the Sahel Nigerien politicians, institutional donors, aid agencies and humanitarian organisations clashed on the nature and substance of the crisis affecting Niger in 2005. Identifying the causes of, and adequate responses to, the situation also gave rise to profound disagreements. Having set up their most ambitious emergency nutrition programme to date, Médecins Sans Frontières found itself at the forefront of these controversies.
Read more
Mohamad Cheblak/MSF
Review
05/07/2021
Michaël Neuman
Natalie Roberts
We can all agree that the emergence of Covid-19 vaccine is “an absolutely astonishing development”, but vaccines are unlikely to completely halt the spread of the virus, let alone eradicate it. Yet even without achieving herd immunity, the ability to vaccinate vulnerable people seems to be reducing hospitalizations and deaths from Covid-19.
Read more
Clément Mahoudeau/MSF
Analysis
12/02/2020
Michaël Neuman
Emmanuel Baron
In this paper, the two authors examine certain aspects of the French response to the epidemic in the light of the experience of Médecins Sans Frontières (MSF) in that field, primarily with respect to the relationship between the actors of the response and the beneficiaries.
Read more
Mariana Abdalla/MSF
Opinion
02/19/2021
Jean-Hervé Bradol
Isabelle Defourny
Blog written by Jean-Hervé Bradol, director of studies at the Crash.
Today, in order to obtain supplies of vaccines against Covid-19, there is neither a major difficulty related to price, nor a major obstacle related to intellectual property rules, nor a deficit in bio-medical research. However, these three topics are generally at the heart of MSF's communication in the area of access to medical care for those in most need. Our discourse must therefore evolve.
With the emergence of worrying variants of the virus present in the early stages of the pandemic and, as a consequence, the need to vaccinate on a global scale as quickly as possible, the world is facing a double challenge: biological engineering and ultra-industrial production – “ultra” echoing the need to produce on a global scale in a short period of time.
Read more
MSF/Arlette Blanco
Review
11/20/2020
Michaël Neuman
Natalie Roberts
After a few months of respite the coronavirus epidemic has resumed its spread. With the second wave becoming a reality in many European countries, the Crash team decided to share some recent reading on the biomedical, political and social aspects of the pandemic in an attempt to shed some light on this tragic Season 2. As in previous editions, some articles are in English and some in French, and they are taken from both mainstream and specialist sources.
Read more
MSF/Rowan Pybus
Analysis
07/22/2020
Marc Le Pape
In France, from March onwards, many sociologists regularly appear in the media. Based on this observation, Marc Le Pape analysed 37 articles written during the containment period, dealing with the Covid-19 pandemic.
Read more
Conference
10/08/2020 - 06:00 PM 08:00 PM
Pierre Chirac
Pierre Chirac, pharmacist and editor of the journal Prescrire, presented his analysis of the pharmaceutical industry's influence strategies and the special interests of university hospital researchers, their consequences on the reliability of drug information and the means now required to rectify a harmful situation.
Read more